BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21725256)

  • 1. Middle fossa decompression for hearing preservation: a review of institutional results and indications.
    Slattery WH; Hoa M; Bonne N; Friedman RA; Schwartz MS; Fisher LM; Brackmann DE
    Otol Neurotol; 2011 Aug; 32(6):1017-24. PubMed ID: 21725256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing preservation and facial nerve outcomes in vestibular schwannoma surgery: results using the middle cranial fossa approach.
    Arts HA; Telian SA; El-Kashlan H; Thompson BG
    Otol Neurotol; 2006 Feb; 27(2):234-41. PubMed ID: 16436995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term hearing preservation after middle fossa removal of vestibular schwannoma.
    Friedman RA; Kesser B; Brackmann DE; Fisher LM; Slattery WH; Hitselberger WE
    Otolaryngol Head Neck Surg; 2003 Dec; 129(6):660-5. PubMed ID: 14663432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle fossa approach for resection of vestibular schwannoma: impact of cochlear fossa extension and auditory monitoring on hearing preservation.
    Vincent C; Bonne NX; Guérin C; Lebreton JP; Devambez M; Dubrulle F; Haddad E; Schapira S; Lejeune JP; Vaneecloo FM
    Otol Neurotol; 2012 Jul; 33(5):849-52. PubMed ID: 22699993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.
    Slattery WH; Fisher LM; Hitselberger W; Friedman RA; Brackmann DE
    J Neurosurg; 2007 Apr; 106(4 Suppl):255-60. PubMed ID: 17465357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of hearing preservation after microsurgical treatment of vestibular schwannoma using the middle cranial fossa approach.
    Wang AC; Chinn SB; Than KD; Arts HA; Telian SA; El-Kashlan HK; Thompson BG
    J Neurosurg; 2013 Jul; 119(1):131-8. PubMed ID: 23413947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hearing preservation in neurofibromatosis type 2.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vestibular schwannoma volume as a predictor of hearing outcome after surgery.
    Gjuric M; Mitrecic MZ; Greess H; Berg M
    Otol Neurotol; 2007 Sep; 28(6):822-7. PubMed ID: 17554228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fundal fluid as a predictor of hearing preservation in the middle cranial fossa approach for vestibular schwannoma.
    Goddard JC; Schwartz MS; Friedman RA
    Otol Neurotol; 2010 Sep; 31(7):1128-34. PubMed ID: 20657334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nerve of origin, tumor size, hearing preservation, and facial nerve outcomes in 359 vestibular schwannoma resections at a tertiary care academic center.
    Jacob A; Robinson LL; Bortman JS; Yu L; Dodson EE; Welling DB
    Laryngoscope; 2007 Dec; 117(12):2087-92. PubMed ID: 17921903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hearing preservation in conservation surgery for vestibular schwannoma.
    Holsinger FC; Coker NJ; Jenkins HA
    Am J Otol; 2000 Sep; 21(5):695-700. PubMed ID: 10993461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of nerve branch of origin and extracanalicular extension of the tumor on hearing after middle fossa removal of vestibular schwannoma.
    Fiscina F; Gouveris H; Mann W
    Acta Otolaryngol; 2007 Oct; 127(10):1058-61. PubMed ID: 17851965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing preservation after middle fossa vestibular schwannoma removal: are the results durable?
    Quist TS; Givens DJ; Gurgel RK; Chamoun R; Shelton C
    Otolaryngol Head Neck Surg; 2015 Apr; 152(4):706-11. PubMed ID: 25628370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hearing preservation using the middle fossa approach for the treatment of vestibular schwannoma.
    Kutz JW; Scoresby T; Isaacson B; Mickey BE; Madden CJ; Barnett SL; Coimbra C; Hynan LS; Roland PS
    Neurosurgery; 2012 Feb; 70(2):334-40; discussion 340-1. PubMed ID: 21826031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Facial nerve function and hearing preservation experience in middle fossa approach removal of small acoustic tumor surgery].
    Yu JB; Wu H; Huang Q; Yang J; Wang ZY; Lü JR
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 48(10):793-7. PubMed ID: 24406173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hearing preservation surgery for vestibular schwannoma: experience with the middle fossa approach.
    DeMonte F; Gidley PW
    Neurosurg Focus; 2012 Sep; 33(3):E10. PubMed ID: 22937844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Middle fossa approach for hearing preservation with acoustic neuromas.
    Slattery WH; Brackmann DE; Hitselberger W
    Am J Otol; 1997 Sep; 18(5):596-601. PubMed ID: 9303156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.